Fragmento

Further to a Consensus Conference in Edinburgh, the UK published guidelines with indications for leucodepletion (LD) in 1998. These were: • For intrauterine transfusions and for neonates andinfants up to one year of age. • Severe aplastic anaemia, to reduce allograft failure. • When CMV-safe components are indicated. • To manage/prevent febrile non-haemolytic transfusion reactions (FNHTR) for long-term red cell transfusion-dependent patients (e.g. thalassaemics) or where the use of buffy code depleted components does not work.

Palabras clave:

2004-11-17   |   1,869 visitas   |   Evalua este artículo 0 valoraciones

Vol. 140 Núm.3. Septiembre-Octubre 2004 Pags. 41 Gac Méd Méx 2004; 140(Supl. 3)